Xtant Medical Holdings (XTNT) Liabilities and Shareholders Equity (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $94.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity changed 0.33% year-over-year to $94.1 million in Q4 2025; TTM through Dec 2025 was $399.8 million, a 4.59% increase from a year earlier, with the FY2025 full-year figure at $94.1 million, changed 0.33% from the prior year.
• Liabilities and Shareholders Equity was $94.1 million for Q4 2025 at Xtant Medical Holdings, down from $106.3 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $106.3 million in Q3 2025 and troughed at $52.7 million in Q2 2022.
• A 5-year average of $77.3 million and a median of $78.6 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity declined 11.67% in 2022 and jumped 64.15% in 2023, its largest moves.
• Over 5 years, Liabilities and Shareholders Equity stood at $54.7 million in 2021, then grew by 10.12% to $60.2 million in 2022, then soared by 53.77% to $92.6 million in 2023, then grew by 1.32% to $93.8 million in 2024, then gained by 0.33% to $94.1 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $94.1 million (Q4 2025), $106.3 million (Q3 2025), and $103.5 million (Q2 2025), per Business Quant data.